Three of the 11 hub genes had previously known drug-gene interactions, that is, PI3 and DSP which were up-regulated in OLP and oral cancer, and IVL which was up-regulated in OLP and early-stage oral cancer. This evidence concerns the gene PI3 and lip and oral cavity carcinoma.